Laboratory

Highlight on the DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay

Clinical

Discovers our solutions

Autorisation de l’ANSM à mettre sur le marché le réactif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations

Jun 18, 2021

Autorisation de mise sur le marché du dispositif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations Nous avons le plaisir d’annoncer la disponibilité immédiate* du dispositif médical UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations, permettant, par amplification gén…
ABL Announces Distribution Agreement with AN BINH MEDICAL in Vietnam

May 31, 2021

Advanced Biological Laboratories (ABL) S.A. and An Binh Medical are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Vietnam. See current channel partners.
Read more
Advanced Biological Laboratories Receives CE-IVD Registration for its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the First CE-IVD Marked Kit for SARS-CoV-2 genotyping clinical applications

May 25, 2021

SARS-CoV-2 Genotyping using Next Generation Sequencing (NGS) Now Suited to Small, Medium and High-throughput Clinical Settings. Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the first in-vitro diagnostics kit…
Read more

COMMUNIQUÉ DE PRESSE – COVID-19 : effervescence d’innovations dans le Grand Est

May 19, 2021

Première région touchée par la pandémie, le Grand Est est également la première région qui a mobilisé avec succès, depuis le début de la crise sanitaire, l’intégralité de son écosystème santé avec le soutien du pôle de compétitivité BioValley France. La COVID-19 nous prouve aujourd’hui que le dévelo…
Read more
Spring SPECIAL OFFER

May 10, 2021

You are a new Client ? This offer is made for you !! Get your free sample kit among all our microbiology genotyping assays (SANGER or Next Generation Sequencing) Offer Available Un…
Read more
ABL Announces Distribution Agreement with ROCHE SISTEMAS DE DIAGNÓSTICOS, LDA in Portugal

Apr 27, 2021

Advanced Biological Laboratories (ABL) S.A. and Roche Diagnostics are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Portugal. See current channel partners.
Read more

Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene SARS-CoV-2 Triplex Assay

Apr 26, 2021

Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its UltraGene® SARS-CoV-2 Triplex Assay, now available for in-vitro diagnostics use. This innovative test is a real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2and genomic variatio…
Read more
UltraGene Assay SARS-CoV-2 Multi Variants Deletions V1 for Screening & Identification of 3 different SARS-CoV-2 Variants is now CE-IVD Marked

Apr 06, 2021

ABL is pleased to announce today that the UltraGene Assay SARS-CoV-2 Multi Variants Deletions V1, a direct qPCR assay to be used on already SARS-CoV-2 positive samples (no need to do additional RNA isolation), received CE-IVD Marking. The kit, targeting 5 different genomic variations on 3 genes in a…
Read more
Innovative And Reliable Turnkey Solution For SARS-CoV-2 Detection And Variants Monitoring

Mar 10, 2021

For more information please contact us at the following email address: contact@ablsa.com
Read more